Cargando…
Blood lipid levels, statin therapy and the risk of intracerebral hemorrhage
Dyslipidemia has been proven to play an important role in the occurrence and development of the ischemic stroke and lipid-lowering therapy could significantly decrease the risk of the ischemic stroke. However, the association between lipid levels, lipid-lowering therapy and the risk of intracerebral...
Autores principales: | Ma, Yingxu, Li, Zhaokai, Chen, Liang, Li, Xiangping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774119/ https://www.ncbi.nlm.nih.gov/pubmed/26932585 http://dx.doi.org/10.1186/s12944-016-0213-8 |
Ejemplares similares
-
Management of intracerebral hemorrhage–use of statins
por: Van Matre, Edward T, et al.
Publicado: (2016) -
Effect of Statin Therapy on Mortality and Recurrence of Intracerebral Hemorrhage in Patients With Spontaneous Intracerebral Hemorrhage
por: Jamil, Sidra, et al.
Publicado: (2022) -
Is the Benefit of Antithrombotics and Statins Worth the Risk of Intracerebral Hemorrhage?: It Depends
por: Gutierrez, Jose
Publicado: (2021) -
Blood-Based Biomarkers in Intracerebral Hemorrhage
por: Lv, Xin-Ni, et al.
Publicado: (2023) -
Statins on Spontaneous Intracerebral Hemorrhage: A Meta-Analysis
por: Liu, Xiaojiao, et al.
Publicado: (2022)